Newsroom

SAN DIEGO--(BUSINESS WIRE)--LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,...

LAUSANNE, Switzerland & SAN JOSE, Calif.--(BUSINESS WIRE)--Logitech G Streamlabs today announced Network Boost, a new mobile feature for Streamlabs Ultra that helps creators improve stream reliability by combining multiple internet connections using the devices they already own. As IRL streaming skyrockets, with Twitch viewers consuming over 391 million hours of IRL content last year alone, unstable cellular connections on crowded convention floors or city streets remain a massive barrier. Hist...

SENDAI, Japan--(BUSINESS WIRE)--Adtran today announced that TOHKnet has completed Japan’s first live network trial demonstrating the coexistence of 50G PON, XGS-PON and EPON on a single fiber. Conducted in Sendai using Adtran’s SDX 6400 Series OLT, the demo showed how the platform enables three generations of PON technology to operate together in a live service environment. The results highlight a realistic path for operators to introduce 50G PON capacity while maintaining continuity for existi...

PARIS--(BUSINESS WIRE)--Evexta Bio S.A., une société d'oncologie de précision fondée par Truffle Capital (fondateur d'Abivax et de Carvolix) et consacrée à la découverte et au développement de thérapies ciblées, annonce aujourd'hui la signature d’un contrat de collaboration clinique et d’approvisionnement afin d’effectuer une étude de phase 1b associant son principal candidat médicament, le rupitasertib, avec un produit en développement de Roche, le giredestrant, un dégradateur sélectif des réc...

PARIS--(BUSINESS WIRE)--Evexta Bio S.A., a precision oncology company, founded by Truffle Capital (founder of Abivax and Carvolix), and focused on the discovery and development of targeted therapies, today announced a clinical collaboration and supply agreement with plans to initiate a Phase 1b study combining its lead investigational compound, rupitasertib, with Roche’s investigational compound giredestrant, a selective estrogen receptor degrader (SERD), for the treatment of ER+, HER2-, ESR1-m...

CAMBRIDGE, England--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologis...

TOKYO--(BUSINESS WIRE)--The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@G...

東京--(BUSINESS WIRE)--（ビジネスワイヤ） -- 東京都は、東京の夜を彩る新たな観光資源創出に向け、都庁舎をキャンバスに光と音で多彩なアートを表現するプロジェクションマッピングを通年上映しています。 このたび、世界中で親しまれているバーチャルシンガー「初音ミク」を起用した作品『HATSUNE MIKU LIGHTS TOKYO』 の初回上映を7月25日(土)に行いました。人気楽曲『M@GICAL☆CURE! LOVE ♥ SHOT!』の世界観を、都庁舎の壁面いっぱいに表現しています。 2024年2月に開始した本取組は、国内外からの多くのご来場をいただき、2026年7月時点で累計観覧者が155万人を突破いたしました。 東京の新たな観光名所として、高い芸術性や世界をリードする技術・コンテンツ等によって生み出される本取組に、引き続きご注目ください。 『HATSUNE MIKU LIGHTS TOKYO』公開初日の様子 （公開初週の土日は約6,700人が観覧） 『HATSUNE MIKU LIGHTS TOKYO』公開初週の土日は、国内外の観光客や家族連れなど約6,700人...

LONDON--(BUSINESS WIRE)--Trumpet, the number one Digital Sales Room and fastest trending sales tool globally on G2 today launched trumpet Copilot: an AI execution layer that changes how revenue teams build Sales Rooms, surface data, create content, and run their entire buyer-facing revenue cycles. Revenue teams spend too much time switching between tools, copying context, and doing the administrative work that gets in the way of selling and retaining customers. Copilot is built to change that....

MILANO--(BUSINESS WIRE)--Bending Spoons S.p.A. (NASDAQ: BSP) ha annunciato di aver stipulato un accordo definitivo per l'acquisizione di Airtable, in una transazione interamente in denaro che valuta Airtable a un enterprise value di 1,285 miliardi di dollari. Tale cifra, insieme all'attuale saldo netto di liquidità e mezzi equivalenti di Airtable, implica un equity value di circa 2,25 miliardi di dollari. L’acquisizione è soggetta alle consuete condizioni e autorizzazioni per la chiusura, inclu...